Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

STA Provision of Investigational Medicinal Product (IMP) and placebo

University Hospitals Bristol and Weston NHS Foundation Trust

This public procurement record has 1 release in its history.

Award

23 Oct 2026 at 16:07

UK5 - Transparency Notice
Summary of the contracting process

Bristol NHS Foundation Trust is procuring investigational medicinal product (IMP) and placebo for a clinical study. The products must be formulated and manufactured under aseptic conditions, requiring specialised pharmaceutical production. The procurement is categorised as pharmaceutical products. Delivery is stated as being in the United Kingdom, without a more specific delivery location. The requirement is for a single lot and is focused on supplying the IMP and placebo to the required formulation and manufacturing specifications. The buyer’s rationale describes a narrow market: other NHS pharmacy aseptic services approached during the funding application could not meet the specification. This is therefore a specialist medicines-manufacturing requirement rather than a general pharmacy supply contract.

The procurement has been awarded through a direct award, justified by niche supply and the limited number of providers able to meet the requirement. Liverpool University Hospital NHS Foundation Trust, trading as MIAA, was selected as supplier. The award is recorded as pending. The award value is £152,440 including gross value. The contract period is 1 December 2026 to 31 December 2032, with signature scheduled for 23 November 2026. The award date is not stated. The process comprised one lot, marked complete. No evaluation scoring or other award criteria are set out; the stated basis for selecting the supplier was the specialist requirement and the inability of other approached NHS aseptic services to meet it.

For a future requirement from Bristol NHS Foundation Trust, a credible competitor would need proven capability to formulate and manufacture investigational medicines and placebo under aseptic conditions, and to meet the study’s precise product specifications. The procurement rationale indicates that this is a highly specialised service with few providers able to satisfy the technical requirement; ordinary pharmaceutical distribution or routine pharmacy aseptic services would not be enough. Suppliers should be able to demonstrate the facilities, quality systems, technical expertise and capacity needed for specialised aseptic manufacture, alongside experience delivering investigational products for clinical research. The selected supplier was a large NHS foundation trust trading as MIAA, showing that the buyer accepted an NHS provider for this requirement. The commercial opportunity is consequently suited to specialist manufacturers or capable NHS aseptic providers, not broad-market suppliers.

How relevant is this notice?

Notice Information

Notice Title

STA Provision of Investigational Medicinal Product (IMP) and placebo

Notice Description

IMP/placebo formulation type it needs to be manufactured in aseptic conditions. This requires a highly specialised manufacturing process and as a result UK Manufacturers of Aseptic servicesable to offer this srvice is are limited. During the grant (funding) application stage 5 other NHS pharmacy aseptic services were approached to provided a quote for the service - all of which were unable to provide the service to the required specifications.

Procurement Information

Niche supply, limited providers who on investigation could not meet the needs of the requirement

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-078f7f
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/100701-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK5 - Transparency Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£152,440 £100K-£500K
Contracts Value
Not specified

Notice Dates

Publication Date
23 Oct 20263 days ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
1 Dec 2026 - 31 Dec 2032 Over 5 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Pending
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
University Hospitals Bristol and Weston NHS Foundation Trust
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
BRISTOL
Postcode
BS1 3NU
Postcode Area
Bristol
Country
England
Major Region (ITL 1)
TLK South West (England)
Basic Region (ITL 2)
TLK5 West of England
Small Region (ITL 3)
TLK51 Bristol, City of
Delivery Location
Not specified
Local Authority
Bristol, City of
Electoral Ward
Central
Westminster Constituency
Bristol Central

Supplier Information

Number of Suppliers
1
Supplier Name

Liverpool University Hospital NHS FT

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...